azumolene has been researched along with oxazoles in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.76) | 18.7374 |
1990's | 9 (42.86) | 18.2507 |
2000's | 4 (19.05) | 29.6817 |
2010's | 6 (28.57) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Coronado, R; el-Hayek, R; Hogan, K; Parness, J; Valdivia, HH | 1 |
Allen, PD; López, JR; Ryan, JF; Sánchez, V; Sreter, FA | 1 |
Denborough, MA; Foster, PS; Hopkinson, KC; Payne, N | 1 |
Katz, AM; Kim, DH; Tian, Q | 1 |
Dershwitz, M; Sréter, FA | 1 |
Leslie, GC; Part, NJ | 1 |
Gallant, EM; Lentz, LR; Taylor, SR | 1 |
Palnitkar, SS; Parness, J | 1 |
Hotchkiss, RS; Karl, IE; Lappas, GD; Osborne, DF | 1 |
Davies, DC; Joel, S; Lister, TA; Salam, AH; Shamash, J; Williams, A | 1 |
Rodney, GG; Schneider, MF; Zhang, Y | 1 |
Butler, T; Klein, MG; McKinney, LC; Mullen, SP | 1 |
Brotto, M; Han, X; Ma, J; Pan, Z; Parness, J; Weisleder, N; Zhao, X | 1 |
Carmo, PL; Sudo, RT; Trachez, MM; Zapata-Sudo, G | 1 |
das Graças Fernandes Sales, M; do Carmo, PL; Sudo, RT; Trachez, MM; Zapata-Sudo, G | 1 |
Kim, DH; Ko, JK; Ma, J; Min, CK; Parness, J; Weisleder, N; Zhao, X | 1 |
Bayarsaikhan, M; Bina, S; Bunger, R; Capacchione, J; Muldoon, S | 1 |
Dirksen, RT; Protasi, F; Yarotskyy, V | 1 |
Kwon, OS; Powers, SK; Smuder, AJ; Sollanek, KJ; Talbert, EE; Wiggs, MP | 1 |
Asta, J; Azam, MA; Bokhari, MM; Kichigina, G; Labos, C; Lai, PFH; Massé, S; Nanthakumar, K; Porta-Sánchez, A; Si, D; Sun, H; Yang, P; Zamiri, N | 1 |
Azam, MA; Bouly, M; Chakraborty, P; Lai, PFH; Massé, S; Nanthakumar, K; Niri, A; Riazi, S; Thollon, C | 1 |
21 other study(ies) available for azumolene and oxazoles
Article | Year |
---|---|
Dantrolene and azumolene inhibit [3H]PN200-110 binding to porcine skeletal muscle dihydropyridine receptors.
Topics: Animals; Caffeine; Calcium Channels; Dantrolene; Dihydropyridines; Imidazoles; Isradipine; Malignant Hyperthermia; Muscle Relaxants, Central; Muscles; Oxazoles; Receptors, Cholinergic; Receptors, Nicotinic; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Swine; Tritium | 1992 |
EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine.
Topics: Animals; Calcium; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Imidazoles; Malignant Hyperthermia; Membrane Potentials; Microelectrodes; Muscle Relaxants, Central; Muscles; Oxazoles; Swine | 1992 |
The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle.
Topics: Animals; Caffeine; Calcium-Transporting ATPases; Dantrolene; Halothane; Imidazoles; Malignant Hyperthermia; Muscle Contraction; Muscle Relaxants, Central; Muscles; Oxazoles; Potassium Chloride; Sarcoplasmic Reticulum | 1991 |
Effects of azumolene on doxorubicin-induced Ca2+ release from skeletal and cardiac muscle sarcoplasmic reticulum.
Topics: Animals; Binding, Competitive; Calcium; Doxorubicin; Imidazoles; Muscles; Myocardium; Oxazoles; Rabbits; Receptors, Cholinergic; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 1991 |
Azumolene reverses episodes of malignant hyperthermia in susceptible swine.
Topics: Animals; Halothane; Imidazoles; Injections, Intravenous; Malignant Hyperthermia; Muscle Relaxants, Central; Oxazoles; Swine | 1990 |
The effect of EU4093 (azumolene sodium) on the contraction of intrafusal muscle in the soleus muscle of the anaesthetized rat.
Topics: Anesthesia; Animals; Electric Stimulation; Female; Imidazoles; In Vitro Techniques; Muscle Contraction; Muscle Relaxants, Central; Muscles; Neurons; Oxazoles; Rats; Rats, Inbred Strains | 1989 |
Modulation of caffeine contractures in mammalian skeletal muscles by variation of extracellular potassium.
Topics: Animals; Caffeine; Dantrolene; Drug Synergism; Extracellular Space; Imidazoles; Mice; Muscle Contraction; Muscle Relaxants, Central; Muscle, Skeletal; Oxazoles; Perchlorates; Potassium; Sodium Compounds; Swine | 1995 |
Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum.
Topics: Animals; Binding Sites; Binding, Competitive; Calcium; Calcium Channels; Dantrolene; Hydrogen-Ion Concentration; Imidazoles; Magnesium; Membranes; Muscle Fibers, Fast-Twitch; Muscle Proteins; Osmolar Concentration; Oxazoles; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Subcellular Fractions; Swine | 1995 |
Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin.
Topics: Animals; Biological Transport; Calcium; Cell Compartmentation; Dantrolene; Diltiazem; Endotoxins; Female; Imidazoles; Interleukin-1; Lipopolysaccharides; Mice; Muscle, Skeletal; Oxazoles; Tumor Necrosis Factor-alpha; Viscera | 1995 |
In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Death; Cell Division; Cell Line, Transformed; Cyclophosphamide; Dantrolene; Doxorubicin; Drug Resistance, Multiple; Gene Expression; Genes, bcl-2; Humans; Imidazoles; Lymphocytes; Lymphoma, B-Cell; Nimodipine; Oxazoles; Prednisone; Tumor Cells, Cultured; Vincristine | 1998 |
Effects of azumolene on Ca2+ sparks in skeletal muscle fibers.
Topics: Algorithms; Animals; Calcium Signaling; Dose-Response Relationship, Drug; Electrophysiology; Image Processing, Computer-Assisted; Imidazoles; Muscle Fibers, Skeletal; Muscle Relaxants, Central; Muscle, Skeletal; Oxazoles; Rana pipiens; Ryanodine Receptor Calcium Release Channel | 2005 |
Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia.
Topics: Animals; B-Lymphocytes; Caffeine; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cells, Cultured; Cresols; Dose-Response Relationship, Drug; Humans; Imidazoles; Malignant Hyperthermia; Oxazoles; Ryanodine; Ryanodine Receptor Calcium Release Channel; Swine | 2006 |
Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor.
Topics: Aging; Animals; Calcium; CHO Cells; Cricetinae; Imidazoles; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Oxazoles; Protein Binding; Ryanodine Receptor Calcium Release Channel; Thapsigargin | 2006 |
Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
Topics: Animals; Dantrolene; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Male; Malignant Hyperthermia; Mice; Muscle Contraction; Muscle Relaxants, Central; Muscle, Skeletal; Oxazoles; Solubility | 2008 |
Toxicological evaluation of azumolene after repeated intraperitoneal administration in rats.
Topics: Animals; Caffeine; Dose-Response Relationship, Drug; Imidazoles; Injections, Intraperitoneal; Kidney; Liver; Male; Muscle Contraction; Muscle, Skeletal; Neuromuscular Agents; Oxazoles; Rats; Rats, Wistar; Solubility; Toxicity Tests, Chronic | 2010 |
Increased store-operated Ca2+ entry in skeletal muscle with reduced calsequestrin-1 expression.
Topics: Animals; Biological Transport; Calcium; Calcium-Binding Proteins; Calsequestrin; Extracellular Space; Gene Expression Regulation; Gene Knockdown Techniques; Heat-Shock Response; HEK293 Cells; Humans; Imidazoles; Inverted Repeat Sequences; Malignant Hyperthermia; Mice; Muscle Fibers, Skeletal; Oxazoles; RNA, Small Interfering; Sarcoplasmic Reticulum | 2010 |
Lymphocyte-based determination of susceptibility to malignant hyperthermia: a pilot study in swine.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Adenosine Triphosphate; Animals; Calcium; Chromatography, High Pressure Liquid; Disease Susceptibility; Enzyme Inhibitors; Imidazoles; Inosine; Lymphocytes; Magnesium; Malignant Hyperthermia; Muscle Relaxants, Central; Oxazoles; Oxidative Phosphorylation; Pilot Projects; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Swine; Uncoupling Agents | 2010 |
Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death.
Topics: Acceleration; Anesthetics; Animals; Calcium; Calcium Channels; Calcium-Binding Proteins; Calsequestrin; Death, Sudden; Disease Models, Animal; Electrophysiological Phenomena; Gene Knock-In Techniques; Gene Knockout Techniques; Hot Temperature; Imidazoles; Mice; Muscle Fibers, Skeletal; Oxazoles; Ryanodine Receptor Calcium Release Channel | 2013 |
Blockage of the Ryanodine Receptor via Azumolene Does Not Prevent Mechanical Ventilation-Induced Diaphragm Atrophy.
Topics: Animals; Calcium Channel Blockers; Diaphragm; Enzyme Activation; Female; Imidazoles; Mitochondria; Muscular Atrophy; Oxazoles; Peptide Hydrolases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Respiration, Artificial; Ryanodine Receptor Calcium Release Channel | 2016 |
Essential role of ryanodine receptor 2 phosphorylation in the effect of azumolene on ventricular arrhythmia vulnerability in a rabbit heart model.
Topics: Animals; Disease Models, Animal; Imidazoles; Isolated Heart Preparation; Male; Oxazoles; Phosphorylation; Rabbits; Ryanodine Receptor Calcium Release Channel; Treatment Outcome; Ventricular Fibrillation | 2018 |
Effects of azumolene on arrhythmia substrate in a model of recurrent long-duration ventricular fibrillation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Imidazoles; Oxazoles; Rabbits; Ventricular Fibrillation | 2022 |